epithalon peptide effects on sleep scientific studies vs Thymosin Alpha-1: Longevity and Immunity Empower Sleep

Zhang developed a neutrophil-mediated drug delivery system by anti-cancer drug encapsulation into cationic liposomes, followed by internalization by tumor-associated neutrophils

These are laboratory observations, not personal-outcome predictions

Both were removed from the FDA Category 2 list in April 2026 and are on the July 23 to 24, 2026 advisory agenda, but they cannot be compounded until the committee recommends them and the FDA completes rulemaking, which takes time

In neuroblastoma cells, Epitalon reduced levels of 8-hydroxydeoxyguanosine (8-OHdG), a key marker of oxidative DNA damage that accumulates in aging neurons and is elevated in Alzheimers and Parkinsons disease [51]